SANDFORD D SMITH Insider Trading $SEEL SEELOS THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SANDFORD D SMITH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SANDFORD D SMITH. SANDFORD D SMITH is Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in QLT INC/BC ($QLTI) and Director in APRICUS BIOSCIENCES, INC. ($APRI) and Director in CYTOKINETICS INC ($CYTK) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Neuralstem, Inc. ($CUR) and Director in AKCEA THERAPEUTICS, INC. ($AKCA).
SANDFORD D SMITH in SEELOS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SANDFORD D SMITH: Director
Holdings: 16,160 shares
Current Value: $42,501
Latest Transaction: Jan 08 2018
$SEEL Market Capitalization: $20.96M
$SEEL Previous Close: $2.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SANDFORD D SMITH in SEELOS THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, AKCA, ARIA, CYTK, NVLN, SNCA, SEEL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
| Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.00 | 11,250 | 0 | 16,160 | 4.9 K to 16.2 K (+229.12 %) |
| Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.34 | 9,607 | 3,250 | 49,093 | 39.5 K to 49.1 K (+24.33 %) |
| Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.40 | 8,136 | 3,250 | 39,486 | 31.4 K to 39.5 K (+25.95 %) |
| Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Grant | A | 0.58 | 4,850 | 2,813 | 31,350 | 26.5 K to 31.4 K (+18.30 %) |
| Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | SMITH SANDFORD D | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 |
Page: 1